1. A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. (3rd May 2017) Authors: Laubach, Jacob P.; Moslehi, Javid J.; Francis, Sanjeev A.; San Miguel, Jesús F.; Sonneveld, Pieter; Orlowski, Robert Z.; Moreau, Philippe; Rosiñol, Laura; Faber, Edward A.; Voorhees, Peter; Mateos, Maria‐Victoria; Marquez, Loreta; Feng, Huaibao; Desai, Avinash; van de Velde, Helgi; Elliott, Jenni... Journal: British journal of haematology Issue: Volume 178:Number 4(2017) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗